BEST AUDIENCE ENGAGEMENT – HONORABLE MENTION EllisLab’s Reactivation Campaign
Entrant: Kate Gallagher, Paramore | the digital agency
Audience: B2B
Why They Won:
This year's "gutsiest campaign" award goes to the marketers at EllisLab, who asked their entire database to opt-in for promotional messages (since the request had not been made at sign-up). Even though only 7% opted-in, and the team cut 93% of its database, we commend these marketers for the difficult decision they made to commit to building a strong, qualified list.
- Lead Judge: Adam T. Sutton, Senior Reporter, MECLABS Primary Research
Therapeutic hypothermia has been advocated for neuroprotection in cardiac arrest-induced encephalopathy, neonatal hypoxic-ischemic encephalopathy, traumatic brain injury, stroke, hepatic encephalopathy, and spinal cord injury, and as an adjunct to certain surgical procedures. In this review, we address physiological mechanism of hypothermia to mitigate neurological injury, the trials that have been performed for each of these indications, the strength of the evidence to support treatment with mild/moderate hypothermia.
BEST AUDIENCE ENGAGEMENT – HONORABLE MENTION EllisLab’s Reactivation Campaign
Entrant: Kate Gallagher, Paramore | the digital agency
Audience: B2B
Why They Won:
This year's "gutsiest campaign" award goes to the marketers at EllisLab, who asked their entire database to opt-in for promotional messages (since the request had not been made at sign-up). Even though only 7% opted-in, and the team cut 93% of its database, we commend these marketers for the difficult decision they made to commit to building a strong, qualified list.
- Lead Judge: Adam T. Sutton, Senior Reporter, MECLABS Primary Research
Therapeutic hypothermia has been advocated for neuroprotection in cardiac arrest-induced encephalopathy, neonatal hypoxic-ischemic encephalopathy, traumatic brain injury, stroke, hepatic encephalopathy, and spinal cord injury, and as an adjunct to certain surgical procedures. In this review, we address physiological mechanism of hypothermia to mitigate neurological injury, the trials that have been performed for each of these indications, the strength of the evidence to support treatment with mild/moderate hypothermia.